You have 9 free searches left this month | for more free features.

Condition

Neoplasms (2)

Breast Cancer (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

GlaxoSmithKline (2)

Ottawa Hospital Research Institute (1)

Collaborator

GlaxoSmithKline (1)

Hamilton Health Sciences Corporation (1)

London Regional Cancer Program, Canada (1)

Ontario Institute for Cancer Research (1)

Intervention

gsk3326595 (3)

5-azacitidine (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

gsk3326595

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer Trial (GSK3326595)

Completed

Breast Cancer

GSK3326595

London, Ontario, Canada

St. Joseph's Health Care London

Oct 24, 2022

Tumors Trial in Canada, United States (GSK3326595, 5-Azacitidine)

Terminated

Neoplasms

GSK3326595
5-Azacitidine

Birmingham, Alabama
+7 more

Feb 10, 2022

Tumors Trial in Worldwide (GSK3326595, Pembrolizumab)

Active, not recruiting

Neoplasms

GSK3326595
Pembrolizumab

Denver, Colorado
+16 more

Jun 23, 2022